Efficacy of a Preservative-Free Ophthalmic Spray Containing PER-LIP® Complex and Sodium Hyaluronate in Patients with Dry Eye Disease: A Prospective Interventional Study

Background: Dry eye disease (DED) is a multifactorial ocular surface condition characterized by tear film instability, causing significant morbidity and reduced quality of life. We evaluated short-term clinical changes associated with use of a preservative-free ophthalmic spray based on the PER-LIP® complex (liposomes 4% + perilla seed extract 0.5%) combined with sodium hyaluronate 0.2%, delivered via an APTAR® multi-dose tip-seal system, in patients with mild-to-moderate DED. Methods: This prospective, single-arm, open-label interventional study enrolled patients with confirmed DED (OSDI > 13 and <50, plus at least one objective criterion). The spray was applied 3–4 times daily for 28 days. Outcomes assessed at baseline and Day 28 included OSDI, TBUT, Schirmer I, Oxford staining grade, central precorneal tear film thickness (CPTF), and BCVA. Phenotype analyses were performed by DED phenotype. Results: 36 patients (mean age 68.9 ± 12.2 years; 13 males, 23 females) participated in the study. Statistically significant improvements were observed in OSDI, TBUT, Oxford staining grade, CPTF, Schirmer I, and BCVA after 28 days. OSDI decreased from a median of 23 to 11 (p < 0.0001); TBUT increased from 6 s to 8 s (p < 0.0001); Oxford staining grade decreased from 1 to 0 (p < 0.0001); CPTF increased from 31 μm to 34 μm (p < 0.0001); Schirmer I changed from 9.5 mm to 10.5 mm (p = 0.0258); and BCVA changed from 0.9 to 1.0 (p = 0.0047). Phenotype analysis showed that TBUT improvement was significantly greater in the evaporative DED phenotype (p = 0.0018). Conclusions: A 28-day course of the PER-LIP® complex ophthalmic spray was associated with statistically significant short-term improvements across subjective and objective DED parameters. The differential TBUT response in the evaporative phenotype is hypothesis-generating and requires confirmation in controlled studies. The uncontrolled design, limited sample, exploratory subgroup analysis, and short observation period represent limitations of the outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-17
DOI
https://doi.org/10.3390/jcm15229011
Primary Topic
Ocular Surface and Contact Lens
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Efficacy of a Preservative-Free Ophthalmic Spray Containing PER-LIP® Complex and Sodium Hyaluronate in Patients with Dry Eye Disease: A Prospective Interventional Study

Ivanka Petric Vicković, Valentina Lacmanović Lončar, Ivan Sabol, Giorgio Ciprandi et al.
Journal of Clinical Medicine
Ocular Surface and Contact Lens
article

Efficacy of a Preservative-Free Ophthalmic Spray Containing PER-LIP® Complex and Sodium Hyaluronate in Patients with Dry Eye Disease: A Prospective Interventional Study

Ivanka Petric Vicković, Valentina Lacmanović Lončar, Ivan Sabol, Giorgio Ciprandi, Zoran Vatavuk, Danijel Mikulić
article en

Abstract

Background: Dry eye disease (DED) is a multifactorial ocular surface condition characterized by tear film instability, causing significant morbidity and reduced quality of life. We evaluated short-term clinical changes associated with use of a preservative-free ophthalmic spray based on the PER-LIP® complex (liposomes 4% + perilla seed extract 0.5%) combined with sodium hyaluronate 0.2%, delivered via an APTAR® multi-dose tip-seal system, in patients with mild-to-moderate DED. Methods: This prospective, single-arm, open-label interventional study enrolled patients with confirmed DED (OSDI > 13 and <50, plus at least one objective criterion). The spray was applied 3–4 times daily for 28 days. Outcomes assessed at baseline and Day 28 included OSDI, TBUT, Schirmer I, Oxford staining grade, central precorneal tear film thickness (CPTF), and BCVA. Phenotype analyses were performed by DED phenotype. Results: 36 patients (mean age 68.9 ± 12.2 years; 13 males, 23 females) participated in the study. Statistically significant improvements were observed in OSDI, TBUT, Oxford staining grade, CPTF, Schirmer I, and BCVA after 28 days. OSDI decreased from a median of 23 to 11 (p < 0.0001); TBUT increased from 6 s to 8 s (p < 0.0001); Oxford staining grade decreased from 1 to 0 (p < 0.0001); CPTF increased from 31 μm to 34 μm (p < 0.0001); Schirmer I changed from 9.5 mm to 10.5 mm (p = 0.0258); and BCVA changed from 0.9 to 1.0 (p = 0.0047). Phenotype analysis showed that TBUT improvement was significantly greater in the evaporative DED phenotype (p = 0.0018). Conclusions: A 28-day course of the PER-LIP® complex ophthalmic spray was associated with statistically significant short-term improvements across subjective and objective DED parameters. The differential TBUT response in the evaporative phenotype is hypothesis-generating and requires confirmation in controlled studies. The uncontrolled design, limited sample, exploratory subgroup analysis, and short observation period represent limitations of the outcomes.

Journal of Clinical MedicineVol. 15(22)
University of Molise (IT), University Hospital Centre Zagreb (HR), University of Zagreb (HR), Catholic University of Croatia (HR), Ruđer Bošković Institute (HR), Sisters of Charity Hospital (HR)
Ocular Surface and Contact Lens
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon